FAST BioMedical is a late clinical-stage medical technology company located in Indianapolis. The company’s globally patented technology is being developed to directly measure volume status (Plasma Volume) and kidney function (mGFR) in a clinically actionable way, which has the potential for significant impact on the treatment of patients with heart failure, cardio-renal syndrome, major surgery, sepsis, and acute kidney injury (AKI). FAST BioMedical has completed five clinical studies in Germany and the United States and has a broad global patent portfolio. A 2021 MedTech Innovator Showcase 50 Company. Connect with us at www.fastbiomedical.com or follow us on Twitter: www.twitter.com/fastbiomedical